PRTODAY / NewswireToday Free press release distribution service network

More news: Research
Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Honor Underlines Courtagen Life Sciences’ Commitment to Innovation which Facilitates Breakthroughs in Biomedical Research - Courtagen’s Avantra® Q400 solves unmet need for walk-away multiplexed protein analysis instrument for clinical settings - Courtagen.com
Frost & Sullivan Honor Underlines Courtagen Life Sciences’ Commitment to Innovation which Facilitates Breakthroughs in Biomedical Research

 

NewswireToday - /newswire/ - Mountain View, CA, United States, 2012/02/02 - Courtagen’s Avantra® Q400 solves unmet need for walk-away multiplexed protein analysis instrument for clinical settings - Courtagen.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Based on its recent analysis of the clinical diagnostic tools market, Frost & Sullivan recognizes Courtagen Life Sciences, Inc. with the 2011 North American Frost & Sullivan Award for New Product Innovation. Courtagen’s unique biomarker workstation platform, the Avantra® Q400, is intuitively designed and meets the need for a compact, highly sensitive, low-density multiplexed protein analysis system for research and clinical settings. This platform possesses several advantages for clinical laboratories, allowing clinicians to generate results quickly while keeping the chain of custody clear and simple.

The Avantra® Q400 measures biomarkers in a multiplex fashion, allowing the detection of up to 20 different analytes simultaneously. It can perform sample preparation in less than 4 minutes, and its run times range between 15 to 40 minutes. Furthermore, its easy-to-use design generates a simple walk-away workflow with minimal operator input, nearly eliminating human error. Lastly, with a highly compact design, the instrument features an incredibly small footprint, easily fitting into the smallest laboratories and point-of-care settings.

To work in conjunction with the Avantra® Q400 Workstation, Courtagen developed the QPDx® BioChip line of assays. Each BioChip is a fully self-contained multiplex protein immunoassay used for biomarker analysis in applications such as oncology, wound healing, several inflammatory disorders, biological threat detection, sepsis, and cardiology. Courtagen also offers custom BioChip development for clients with specific or proprietary testing requirements. QPDx® BioChips require only 100 µL of sample per chip, and measures concentrations as low as tens of picograms for highly sensitive detection of the analytes in question.

"QPDx® BioChips provide several advantages, including rapid results in as little as 15 minutes, CVs below 10% for superior reproducibility, and simplicity for all experience levels," said Frost & Sullivan Senior Industry Analyst, Christi Bird. "The entirely self-contained assay eliminates the need for additional reagent preparation, reducing human error and contamination that can cause skewed results."

In addition to its growing product portfolio, Courtagen plans to launch a genomics profiling and interpretation service in March 2012 using next-generation sequencing technology. With this launch, Courtagen will offer both proteomic and genomic solutions for its research and clinical customers.

The management team at Courtagen Life Sciences is relentless in its approach to building effective organizations that not only create great products but are also passionate about serving customers. The company inculcates and emphasizes a team based approach to excellence by driving quality across all operations, including product development, manufacturing, supply chain, and customer support. The firm couples leading edge science with world-class manufacturing techniques such as cell base manufacturing, root cause analysis, and comprehensive cross-training programs in its approach to creating value for its employees, stakeholders and customers.

"Courtagen employs a customer-inspired product development system, ensuring its offerings are of high market value and targets the correct customer base to fill unmet needs," said Bird. "The company calls its strategy,"Right Things, Right People, Right Time", and with the Avantra® Q400 Workstation, they delivered on this promise."

"The company attempts to make its supply chain partners extensions of its business, streamlining the pipeline and developing value-added services along the way," noted Bird. "It also employs a system for driving new product development built on innovation, quality, and productivity, allowing it to achieve rapid product time-to-market products and higher revenues."

Each year, Frost & Sullivan presents this Award to the company that demonstrates innovation in developing a product. The recipient leverages leading edge technologies to offer value-added features while increasing the ROI for customers. In turn, the innovation enables the company to acquire new customers and increase their market penetration.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Courtagen Life Sciences, Inc.
Courtagen Life Sciences (courtagen.com) is a privately held life science company that provides innovative proteomic and genomic products and services to the Life Sciences industry. Founded by innovators in next-generation sequencing (NGS), genetics, molecular biology, and information science, our company deliver tools that enable researchers and clinicians to make better decisions regarding drug development and patient care. Courtagen provides proteomic and genomic solutions through its various operating divisions.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

Contact:
Elizabeth Holland
P: 617-892-7178 / F: 617-892-7191 - E: elizabeth.holland[.]courtagen.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Honor Underlines Courtagen Life Sciences’ Commitment to Innovation which Facilitates Breakthroughs in Biomedical Research

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan | Courtagen Life Sciences
Publisher Contact: Mireya Espinoza 
210-247-3870 mireya.espinoza[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Research Most Recent Related Newswires:

DSM-Niaga Ready for Commercial Scale Production of 100%-recyclable Carpets
DSM Dyneema Introduces Whole New Level of Cut Protection with Black Dyneema® Diamond Technology
DSM Presents Sustainable and Healthy Dairy Solutions At FoodTech 2016
Frost & Sullivan Highlights GENEWIZ's Commitment to Providing Cutting-edge Services in the Life Science Research Services Market
DSM to Present its Latest Advances in Skin Biochemistry At IFSCC Conference
DSM Launches ForTii® Ace Next Generation High Performance Polyamides
DSM Launches New Cultures to Reduce Cheese Ripening Time
DSM Launches New 3C Technology to Reinvigorate Omega-3 Supplements Category
DSM to Highlight its Health and Indulgence Solutions for Baked Goods At IBIE
DSM Welcomes EU Novel Foods Approval for Heart Health Antioxidant
DSM Dyneema Successfully Defends Key Patent Against Competitor Challenge
DSM Expands its Automotive Electronics Portfolio with High-flow Akulon PA66
BD Expands Portfolio of Reproductive and Sexually Transmitted Infections Solutions
BD Announces New Software Release for Pyxis Enterprise Solution
DSM Opens its Asia Pacific Personal Care Technical & Application Center in Shanghai

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)